Literature DB >> 8698463

Bacterial persistence and immunity in goats vaccinated with a purE deletion mutant or the parental 16M strain of Brucella melitensis.

N F Cheville1, S C Olsen, A E Jensen, M G Stevens, A M Florance, H S Houng, E S Drazek, R L Warren, T L Hadfield, D L Hoover.   

Abstract

To evaluate host responses, young goats were inoculated subcutaneously with a genetic deletion mutant (deltapurE201) of Brucella melitensis (n = 6), its virulent parental strain 16M (n = 6), or saline (n = 6). No clinical evidence of brucellosis was seen in any goat. Serum antibody titers peaked at postinoculation day (PID) 14. Bacteria in lymph nodes that drained sites of vaccination reached peak numbers of >10(6) CFU/g in both infected groups at PID 7 and progressively declined to PID 84. At necropsy, bacteria were present in mammary lymph nodes or spleen of 33% of goats given virulent 16M but in none of goats given the purE mutant. Lymphadenitis, most severe in goats given 16M, involved depletion of lymphocytes and germinal centers, proliferation of lymphoblasts, and vasculitis. By PID 28, lymph node architecture was restored; there was marked germinal center formation and medullary plasmacytosis. Brucellar antigens, detected with immunoperoxidase techniques, were prominent in capsular granulomas but not in lymph node cortices. Ultrastructurally, bacteria were found in macrophages (>97%) and small lymphocytes (<3%) but not in large lymphocytes. Bacteria were intact in small lymphocytes but in macrophages were in various stages of degradation. The deltapurE phenotype of deltapurE201 was preserved during infection of goat lymph nodes. Unlike Salmonella spp. purE mutants, strain deltapurE201 may be a candidate for efficacy testing; it produced immune responses, was cleared from visceral tissues, and produced less severe pathologic changes than its wild-type parent.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698463      PMCID: PMC174094          DOI: 10.1128/iai.64.7.2431-2439.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  THE EFFECT OF OPSONIZATION WITH ANTISERUM ON THE SURVIVAL OF BRUCELLA ABORTUS WITHIN BOVINE PHAGOCYTES.

Authors:  H SMITH; R B FITZGEORGE
Journal:  Br J Exp Pathol       Date:  1964-12

2.  Virulence of a nutritional mutant of Vibrio comma.

Authors:  S B FORMAL; H BOHNER; H SCHNEIDER; L S BARON
Journal:  Proc Soc Exp Biol Med       Date:  1960-02

3.  Deletion of purE attenuates Brucella melitensis infection in mice.

Authors:  R M Crawford; L Van De Verg; L Yuan; T L Hadfield; R L Warren; E S Drazek; H H Houng; C Hammack; K Sasala; T Polsinelli; J Thompson; D L Hoover
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

4.  Deletion of the BCSP31 gene of Brucella abortus by replacement.

Authors:  S M Halling; P G Detilleux; F M Tatum; B A Judge; J E Mayfield
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

5.  Effect of a purA mutation on efficacy of Salmonella live-vaccine vectors.

Authors:  D F Sigwart; B A Stocker; J D Clements
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

6.  Evaluation of serological tests for diagnosis of Brucella melitensis infection of goats.

Authors:  E Díaz-Aparicio; C Marín; B Alonso-Urmeneta; V Aragón; S Pérez-Ortiz; M Pardo; J M Blasco; R Díaz; I Moriyón
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

7.  Detection of restriction fragment length polymorphisms in clinical isolates and serially passaged Pseudomonas aeruginosa strains.

Authors:  L N Hjelm; A A Branstrom; R L Warren
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

8.  Histopathologic findings in Brucella abortus-infected, pregnant goats.

Authors:  V P Meador; W A Hagemoser; B L Deyoe
Journal:  Am J Vet Res       Date:  1988-02       Impact factor: 1.156

9.  Protection of mice against Brucella abortus infection by inoculation with monoclonal antibodies recognizing Brucella O-antigen.

Authors:  M Phillips; B L Deyoe; P C Canning
Journal:  Am J Vet Res       Date:  1989-12       Impact factor: 1.156

10.  Comparative analysis of immune responses in cattle vaccinated with Brucella abortus strain 19 or strain RB51.

Authors:  M G Stevens; S C Olsen; N F Cheville
Journal:  Vet Immunol Immunopathol       Date:  1995-02       Impact factor: 2.046

View more
  10 in total

1.  Protection against brucellosis in goats, five years after vaccination with reduced-dose Brucella melitensis Rev 1 vaccine.

Authors:  E Díaz-Aparicio; L Hernández; F Suárez-Güemes
Journal:  Trop Anim Health Prod       Date:  2004-02       Impact factor: 1.559

2.  Lymphocyte proliferative responses of goats vaccinated with Brucella melitensis 16M or a delta purE201 strain.

Authors:  S C Olsen; N F Cheville; M G Stevens; H H Houng; E S Drazek; T L Hadfield; R L Warren; D L Hoover
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

3.  Recombinant Ochrobactrum anthropi expressing Brucella abortus Cu,Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 type.

Authors:  Yongqun He; Ramesh Vemulapalli; Gerhardt G Schurig
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

4.  Protection against infection in mice vaccinated with a Brucella abortus mutant.

Authors:  M L Boschiroli; S L Cravero; A I Arese; E Campos; O L Rossetti
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

Review 5.  Survival of the fittest: how Brucella strains adapt to their intracellular niche in the host.

Authors:  R Martin Roop; Jennifer M Gaines; Eric S Anderson; Clayton C Caswell; Daniel W Martin
Journal:  Med Microbiol Immunol       Date:  2009-09-22       Impact factor: 3.402

6.  Intact purine biosynthesis pathways are required for wild-type virulence of Brucella abortus 2308 in the BALB/c mouse model.

Authors:  Rosemarie B Alcantara; Richard D A Read; Michelle Wright Valderas; Timothy D Brown; R Martin Roop
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

7.  Progress in Brucella vaccine development.

Authors:  Xinghong Yang; Jerod A Skyberg; Ling Cao; Beata Clapp; Theresa Thornburg; David W Pascual
Journal:  Front Biol (Beijing)       Date:  2013-02-01

Review 8.  Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans.

Authors:  Jinkyung Ko; Gary A Splitter
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

9.  Evaluation of shedding, tissue burdens, and humoral immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence vaccine strain Rev. 1.

Authors:  Jennifer L Higgins; Mercedes Gonzalez-Juarrero; Richard A Bowen
Journal:  PLoS One       Date:  2017-10-13       Impact factor: 3.240

10.  Evaluation of the General Organization of Veterinary Services control program of animal brucellosis in Egypt: An outbreak investigation of brucellosis in buffalo.

Authors:  H I Hosein; Hoda Mohamed Zaki; Nesreen Mohamed Safwat; Ahmed M S Menshawy; Sherin Rouby; Ayman Mahrous; Bahaa El-Deen Madkour
Journal:  Vet World       Date:  2018-06-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.